Navellier & Associates’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-51,158
Closed -$3.78M 313
2023
Q2
$3.78M Buy
+51,158
New +$3.9M 0.74% 47
2022
Q1
Sell
-85,706
Closed -$7.19M 292
2021
Q4
$7.19M Sell
85,706
-3,702
-4% -$297K 1.05% 22
2021
Q3
$6.98M Buy
+89,408
New +$7.43M 1.05% 28

Other funds holding BRKR

Navellier & Associates's BRKR Position: Q3 2023 in Review

Navellier & Associates sold out of Bruker (BRKR) in Q3 2023, closing a stake of 51,158 shares — an estimated $3.78M sold.

Navellier & Associates first reported a position in BRKR in Q3 2021 and held it in 3 quarters. The position peaked at $7.19M in Q4 2021. 345 funds tracked by Wall St. Rank hold BRKR as of Q3 2023.

  • Navellier & Associates reported no remaining Bruker position as of Q3 2023 after selling out during the quarter.
  • Navellier & Associates sold 51,158 Bruker shares in Q3 2023, an estimated $3.78M.
  • Navellier & Associates first reported a position in Bruker in Q3 2021 and held it in 3 quarters.
  • Navellier & Associates's Bruker position peaked at $7.19M in Q4 2021.
  • 345 funds tracked by Wall St. Rank held Bruker as of Q3 2023.

Based on Navellier & Associates's 13F filing for Q3 2023, filed 9 Nov 2023.